Universal flu shot tested in thousands
NCT ID NCT05569239
Summary
This study is testing a new type of flu vaccine called OVX836. It aims to provide broader protection against many different flu strains, not just the few selected each year. The trial involves 2,850 healthy adults aged 18-59 who will receive either the vaccine or a placebo shot. Researchers will measure how well it prevents confirmed flu illness and check its safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
FI-14
Kokkola, Finland
-
Site BE-01
Ghent, Belgium
-
Site BE-02
Antwerp, Belgium
-
Site BE-03
Antwerp, Belgium
-
Site BE-04
Mechelen, Belgium
-
Site DE-16
München, Germany
-
Site FI-08
Helsinki, Finland
-
Site FI-09
Tampere, Finland
-
Site FI-10
Turku, Finland
-
Site FI-11
Oulu, Finland
-
Site FI-12
Espoo, Finland
-
Site FI-13
Jarvenpaa, Finland
-
Site FI-15
Seinäjoki, Finland
-
Site FR-05
Lyon, France
-
Site FR-06
Rennes, France
-
Site FR-07
Paris, France
Conditions
Explore the condition pages connected to this study.